Detection of a γ interferon-induced protein IP-10 in psoriatic plaques

Journal of Experimental Medicine

Volumn 168, Issue 3, 1988, Pages 941-948

  Gottlieb, Alice B ^a,b   Luster, Andrew D ^c   Posnett, David N ^d   Martin Carteri, D ^b  

^a Departments of Immunology   (United States)

^b Investigative Dermatology ^*  (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

CLINICAL ARTICLE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN IP 10; PROTEIN SYNTHESIS; PSORIASIS;

BLOTTING, NORTHERN; EPIDERMIS; HUMAN; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; KERATIN; PROTEINS; PSORIASIS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023792898     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.168.3.941     Document Type: Article

References (35)

1. Gottlieb, A. B., B. Lifshitz, S. M. Fu, L. Staiano-Coico, C. Y Wang, and D. M. Carter. 1986. Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J. Exp. Med. 164: 1013.
2. Baker, B. S., A. F. Swain, L. Fry, and H. Valdimarsson. 1984. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br. J Dermatol. 11: 555.
3. Terui, T., S. Aiba, T. Tanaka, and H. Tagami. 1987. HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions. Br. J Dermatol. 116: 87.
4. Nathan, C. F., G. Kaplan, W. R. Levis, A. Nusrat, M. D. Witmer, S. A. Sherwin, C. K. Job, C. R. Horowitz, R. M. Steinman, and Z. A. Cohn. 1986. Local and systemic effects of intradermal recombinant interferon-y in patients with lepromatous leprosy. N. Engl. J. Med. 315: 6.
5. Basham, T. Y., B. J. Nickoloff, T C. Merigan, and V. B. Morhenn. 1984. Recombinant γ interferon induces HLA-DR expression on cultured human keratinocytes. J. Invest. Dermatol. 83: 88.
6. Luster, A. D., J. C. Unkeless, and J. V. Ravetch. 1985. γ-Interferon transcriptionally regulates an early response gene containing homology to platelet proteins. Nature (Loud.). 315: 672.
7. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a γ interferon-inducible cytokine (IP-10).J. Exp. Med. 166: 1084.
8. Luster, A. D., and J. V. Ravetch. 1987. Genomic characterization of a γ interferon-inducible gene (IP-10) and identification ofan interferon-inducible hypersensitive site. Mol. Cell. Biol. 7: 3723.
9. Kaplan, G., A. D. Luster, G. Hancock, and Z. A. Cohn. 1987. The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med. 166: 1098.
10. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation ofbiologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18: 5294.
11. Gunning, P., P Ponte, H. Okoyama, J. Engel, H. Blau, and L. Kedes. 1983. Isolation and characterization offull-length cDNA clones for human α, β, and γ-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol. 3: 787.
12. Peehl, D., and R. G. Ham. 1980. Clonal growth ofhuman keratinocytes with small amounts of dialyzed serum. In Vitro. 16: 526.
13. Wang, C. Y., Y. Bushkin, P D. Chen, C. D. Platsoucas, and C. Long. 1984. Preparation and characterization of monoclonal antibodies directed at epitopes ofhuman interferon-y. Hybridoma. 3: 321.
14. Posnett, D. N., H. McGraff, and J. P Tam. 1988. A novel method for producing antipeptide antibodies: Production of site-specific antibodies to the T cell antigen receptor beta chain. J. Biol. Chem. 263: 1719.
15. Gottlieb, A. B. 1988. Immunologic mechanisms in psoriasis.) Am. Acad. Dermatol. 18: 1376.
16. Marx, J. 1988. Cell growth control comes under scrutiny. Science (Wash. DC). 239: 1093.
17. Parker, K., I. Kilian, J. McLane, and D. Sauder. 1988. Identification of high affinity interleukin-1 receptors on human keratinocytes: Potential autocrine role of interleukin-1. Ann. NY Acad. Sci. In press.
18. Gottlieb, A. B., C. K. Chang, D. N. Posnett, B. Fanelli, andJ. P. Tam. 1988. Detection of transforming growth factor a in normal, malignant, and hyperproliferative human keratinocytes. J. Exp. Med. 167: 670.
19. Pittelkow, M. R., and R. J. Coffey. 1988. Transforming growth factor a expression and growth regulation in human keratinocytes.). Invest. Dermatol. 90: 599.
20. Witmer-Pack, M. D., W. Oliver, J. Valinsky, G. Schuler, and R. M. Steinman. 1987. Granulocyte/macrophage colon-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166: 1484.
21. Heufler, C., F. Koch, and G. Schuler. 1988. Granulocyte/macrophag e colon-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167: 700.
22. Kupper, T. S., D. W. Ballard, A. O. Chua, J. S. McGuire, P. M. Flood, M. C. Horowitz, R. Langdon, L. Lightfoot, and U. Gubler. 1986. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 α and β mRNA. J. Exp. Med. 164: 2095.
23. Luger, T. A., B. M. Stadler, and S. I. Katz. 1981. Epidermal cell (keratinocyte) derived thymocyte activating factor. J. Immunol. 127: 1493.
24. Sauder, D. N. 1985. Biologic properties of epidermal cell thymocyte-activating factor (ETAF). J. Invest. Dermatol. 85: 176s.
25. Kupper, T., L. May, N. Birchall, and P. Sehgal. 1988. Keratinocytes produce interleukin 6, a cytokine which can provide a second signal in the activation of T cells. J. Invest. Dermatol. 90: 578.
26. Kock, A., T. Luger, andJ. Ansel. 1988. Expression of IL-6 in human epidermoid carcinoma cells. Clin. Res. 36: 377.
27. Sauder, D. N., D. Wong, R. McKenzie, D. Stetsko, D. Harnish, V. Tron, and B. Nickolofl’. 1988. The pluripotent keratinocyte: Molecular characterization ofepidermal cytokines. J. Invest. Dermatol. 90: 605.
28. 2α in epidermis of psoriasis. Proc. Nad. Acad. Sci. USA. 72: 5130.
29. Kaplan, G., M. D. Witmer, I. Nath, R. M. Steinman, S. Laal, H. K. Prasad, E. N. Sarno, U. Elvers, and Z. A. Cohn. 1986. Influence ofdelayed immune reactions on human epidermal keratinocytes. Proc. Nad. Acad. Sci. USA. 183: 3469.
30. Nanney, L. B., C. M. Stoscheck, M. Magid, and L. E. King, Jr. 1986. Altered 121 1-Epidermal growth factor binding and receptor distribution in psoriasis. J. Invest. Dermatol. 86: 260.
31. Weiss, R. A., G. Y. A. Guillet, I. M. Freedberg, E. R. Farmer, E. A. Small, M. M. Weiss, and T T Sun. 1983. The use ofmonoclonal antibody to keratin in human epidermal disease: Alterations in immunohistochemical staining pattern.f. Invest. Dermatol. 81: 224.
32. Grondahl-Hansen, J., E. Ralfkiaer, L. S. Nielsen, P. Kristensen, F Gerda, and K. Dano. 1987. Immunohistochemical localization of urokinase-and tissue-type plasminogen activators in psoriatic skin. J. Invest. Dermatol. 88: 28.
33. Staiano-Coico, L., A. B. Gottlieb, L. Barazani, and D. M. Carter. 1987. RNA, DNA, and cell surface characteristics of lesional and non-lesional psoriatic skin. J. Invest. Dermatol. 88: 646.
34. Reano, A., M. Faure, Y. Jacques, U. Reichert, H. Schaefer, and J. Thivolet. 1982. Lectins as markers of human epidermal cell differentiation. Differentiation. 22: 205.
35. Talwar, H., G. J. Fisher, and J. J. Voorhees. 1988. sn-1,2-diacylglycerol is increased in psoriatic involved versus uninvolved and normal epidermis. J. Invest. Dermatol. 90: 612.